Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|8|1993-2000

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.8, 2015-08, pp. : 1993-2000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 275-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation

By  

Oncology, Vol. 90, Iss. 3, 2016-02 ,pp. : 160-166

Karger

Access to resources Recommend Favorite

G-CSF in Healthy Allogeneic Stem Cell Donors

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 4, 2013-07 ,pp. : 225-235

Karger

Access to resources Recommend Favorite

Stem Cell Mobilization in Healthy Donors: Current Status

By  

Transfusion Medicine and Hemotherapy, Vol. 26, Iss. 2, 1999-04 ,pp. : 92-95

Karger

Access to resources Recommend Favorite

Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 29-36

Karger

Access to resources Recommend Favorite